Allient (ALNT) CFO receives new time- and performance-based share awards

Rhea-AI Filing Summary

ALLIENT INC Chief Financial Officer James A. Michaud reported multiple share awards of common stock on March 5, 2026. The Form 4 shows three acquisitions of shares as grants or awards, rather than open‑market purchases.

One grant consists of time‑based restricted shares awarded under the Company’s 2017 Omnibus Incentive Plan, vesting one‑third each on April 1, 2027, 2028 and 2029. Additional performance‑based restricted share grants were reported, which will vest over a three‑year period if specified performance goals for the year ending December 31, 2026 are met. A further performance‑based award was earned based on goals for the year ended December 31, 2025 and will vest one‑third each on April 1, 2026, 2027 and 2028.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Michaud James A

(Last) (First) (Middle)

C/O ALLIENT INC.

495 COMMERCE DRIVE

(Street)

AMHERST NY 14228

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLIENT INC [ ALNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		A		2,739(1)	A	$62.07	12,290	D
Common Stock	03/05/2026		A		2,055(2)	A	$62.07	14,345	D
Common Stock	03/05/2026		A		565(3)	A	$62.07	14,910	D
Common Stock								113	I	By ESOP Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.

2. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2026.

3. Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares were earned upon the satisfaction of certain performance goals established by the Compensation Committee for the year ended December 31, 2025 and vest one-third each on April 1, 2026, 2027 and 2028.

	/s/ Michael C. Donlon, Attorney-in-Fact for James A. Michaud	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ALLIENT (ALNT) CFO James A. Michaud report in this Form 4?

James A. Michaud reported receiving multiple grants of common stock awards. These include time‑based and performance‑based restricted shares under Allient’s 2017 Omnibus Incentive Plan, all classified as acquisitions rather than open‑market purchases, with vesting tied to future dates and performance goals.

How many types of share awards did ALLIENT (ALNT) grant to its CFO?

Allient granted three types of share awards to its CFO. These were one time‑based restricted share grant and two separate performance‑based restricted share grants, each with its own vesting schedule and performance conditions linked to compensation decisions by the company’s Compensation Committee.

What are the vesting terms of the time-based restricted shares for ALLIENT (ALNT) CFO?

The time‑based restricted shares vest in three equal installments. According to the filing, they vest one‑third each on April 1, 2027, April 1, 2028 and April 1, 2029, as part of the company’s long‑term incentive compensation for the Chief Financial Officer.

How do the performance-based restricted shares for ALLIENT (ALNT) CFO vest?

One performance‑based grant will vest over a three‑year period if performance goals for the year ending December 31, 2026 are satisfied. Another performance‑based grant was already earned based on 2025 goals and will vest one‑third each on April 1, 2026, 2027 and 2028.

Was the ALLIENT (ALNT) CFO buying or selling shares in the open market?

The Form 4 does not show open‑market buying or selling by the CFO. Instead, all reported acquisitions are grants or awards of restricted common stock under the company’s 2017 Omnibus Incentive Plan, reflecting equity‑based compensation rather than discretionary trading activity.

Does ALLIENT (ALNT) CFO James A. Michaud hold any indirect shares?

Yes, the filing lists an indirect holding of common stock. These shares are held "By ESOP Trust" and are reported separately from his directly owned shares, indicating an additional ownership position through an employee stock ownership plan structure.